All SARS-CoV-2 articles
-
NewsMERS coronavirus vaccine tested as safe and effective in phase Ib clinical trial
The safety, immunogenicity and optimal dosing regimen of the MVA-MERS-S vaccine candidate have been investigated in a phase Ib study in healthy individuals who were previously infected with SARS-CoV-2.
-
NewsCOVID study reveals virus-induced inflammation during pregnancy, redefines vertical transmission
A protein made by SARS-CoV-2 can pass through the placenta and cause serious inflammatory immune responses in the fetus for 66% of pregnancies.
-
NewsStudy helps understand pain associated with viral infection
Through experiments in mice infected with a herpes virus, scientists have identified an immune system sensor that recognizes viral fragments and activates neurons responsible for pain, independently of inflammation.
-
NewsCould a bout of COVID protect you from a severe case of flu?
More than 200 viruses can infect and cause disease in humans; most of us will be infected by several over the course of a lifetime. Does an encounter with one virus influence how your immune system responds to a different one?
-
News$12 million grant to research how vaccines induce lasting immunity
Researchers have received a $12 million grant to study how vaccines trigger long-lasting immune responses. The work may inform the design of new, more protective vaccines for respiratory viruses, including SARS-CoV-2 and influenza.
